Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Advanced Breast Cancer|Quality of Life|Toxicity|Older Patients
Interventions: DRUG: CDK 4/6 inhibitors|DRUG: Endocrine therapy
Sponsor: Region Örebro County
Collaborators: University of Patras|University of Florence|Azienda USL Toscana Centro|Helsinki University Central Hospital|Institute for Medical Technology Assessment - the Netherlands|Security Labs Consulting Limited|Circular Economy Foundation|Universidad Nacional de Educación a Distancia|Hellenic Cooperative Oncology Group|University Hospital, Akershus|Uppsala County Council, Sweden|Hospital Clinic of Barcelona|Phaze Clinical Research & Pharma Consulting|Bröstcancerförbundet|Eunomia Ltd|University of Applied Sciences and Arts Northwestern Switzerland|CareAcross Ltd|Örebro University, Sweden